
|Articles|August 1, 2006
- Pharmaceutical Executive-08-01-2006
- Volume 0
- Issue 0
Getting Better
Is the golden age of drug development over? Fat chance. Decade-by-decade comparisons show how new medicines improve on old ones. And that's innovation.
Advertisement
Articles in this issue
over 19 years ago
Time Machineover 19 years ago
States Curb Marketingover 19 years ago
From the Editor: Take Your Seatover 19 years ago
Viewpoint: In Your Wordsover 19 years ago
Quiz Answersover 19 years ago
Introduction: Pharm Exec at 25over 19 years ago
How Far We've ComeNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Medical Supply Chains at Risk Over Escalating Conflicts in Iran: Report
2
Pharmaceutical Executive Daily: Shah Capital's Plan to Vote Against Novavax Board Nominees
3
Q&A: Supply Chain Fallout From Iran War, Tariff Uncertainty
4
Novavax Stock Increases as Shah Capital Plans to Vote Against Board Nominees
5




